Research only
KLOW
Four-peptide research blend in one vial
- Form
- Lyophilised peptide blend
- Amount
- 80 mg vial
- Purity
- ≥ 99 %
- In stock, ships in 1 business day
- Sealed, moisture-protected packaging
About this product
KLOW is a blend of four synthetic peptides in one vial: GHK-Cu, BPC-157, TB-500 and KPV. Supplied as a lyophilised powder in an 80 mg vial for laboratory research.
Composition
- GHK-Cu – 50 mg. A copper(II) complex of the tripeptide glycyl-histidyl-lysine. GHK itself occurs naturally in human plasma; in research it is mostly used to study fibroblasts and extracellular-matrix (collagen) processes. The copper gives the blend its blue tint.
- BPC-157 – 10 mg. A fifteen-amino-acid peptide – a fragment of a gastric juice protein. Studied in preclinical models of tissue repair and new blood vessel formation.
- TB-500 – 10 mg. A synthetic peptide based on the active region of thymosin β4, an actin-binding protein. Used in cell migration and cytoskeleton research.
- KPV – 10 mg. The tripeptide lysine–proline–valine, the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). Studied in cell models of inflammatory signalling (NF-κB).
Why one vial
These four compounds are often studied in the same research areas. The blend supplies them at a fixed 5 : 1 : 1 : 1 ratio, so there is no need to combine separate vials.
Packaging
A sealed glass vial with an aluminium crimp cap. Every vial carries a batch number and expiry date.
For laboratory research only. Not for human or animal use.
- Purity confirmed
- Batch certificate of analysis (COA)
| GHK-Cu | 50 mg |
|---|---|
| BPC-157 | 10 mg |
| TB-500 | 10 mg |
| KPV | 10 mg |
| Purity | ≥ 99 % |
Store at 2–8 °C, dry and away from light. Let the vial reach room temperature before opening.
For in-vitro research use only. Not a medicine or food supplement. Not for human or animal use. Research use policy
Related products
GLP-1 / GIP agonists
Retatrutide
Triple GIP, GLP-1 and glucagon receptor agonist for research
from €75.00
Select mg
